BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18473838)

  • 21. Structural analysis of farnesyl pyrophosphate synthase from parasitic protozoa, a potential chemotherapeutic target.
    Srivastava A; Mukherjee P; Desai PV; Avery MA; Tekwani BL
    Infect Disord Drug Targets; 2008 Mar; 8(1):16-30. PubMed ID: 18473904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
    Bacchi CJ; Yarlett N
    Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
    McKerrow JH
    Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New drugs for the treatment of human parasitic protozoa].
    Dupouy-Camet J
    Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An introduction to the structural organization of parasitic protozoa.
    de Souza W
    Curr Pharm Des; 2008; 14(9):822-38. PubMed ID: 18473832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mannose-6-phosphate receptors for lysosomal enzymes cycle between the Golgi complex and endosomes.
    Brown WJ; Goodhouse J; Farquhar MG
    J Cell Biol; 1986 Oct; 103(4):1235-47. PubMed ID: 2945825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Target points of antiparasitic drugs].
    Boczoń K
    Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
    [No Abstract]   [Full Text] [Related]  

  • 28. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
    Biñas M; Johnson AM
    Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of coated vesicles bearing mannose 6-phosphate receptors for lysosomal enzymes in the Golgi region of I-cell fibroblasts.
    Brown WJ; Farquhar MG
    Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5135-9. PubMed ID: 6147848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal compartments: class E vps phenotype in mammalian cells.
    Fujita H; Yamanaka M; Imamura K; Tanaka Y; Nara A; Yoshimori T; Yokota S; Himeno M
    J Cell Sci; 2003 Jan; 116(Pt 2):401-14. PubMed ID: 12482925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reporter genes facilitating discovery of drugs targeting protozoan parasites.
    Dube A; Gupta R; Singh N
    Trends Parasitol; 2009 Sep; 25(9):432-9. PubMed ID: 19720564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
    Ali V; Nozaki T
    Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endolyn-78, a membrane glycoprotein present in morphologically diverse components of the endosomal and lysosomal compartments: implications for lysosome biogenesis.
    Croze E; Ivanov IE; Kreibich G; Adesnik M; Sabatini DD; Rosenfeld MG
    J Cell Biol; 1989 May; 108(5):1597-613. PubMed ID: 2654137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a recycling role for Rab7 in regulating a late step in endocytosis and in retention of lysosomal enzymes in Dictyostelium discoideum.
    Buczynski G; Bush J; Zhang L; Rodriguez-Paris J; Cardelli J
    Mol Biol Cell; 1997 Jul; 8(7):1343-60. PubMed ID: 9243512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.
    Soeiro MN; Werbovetz K; Boykin DW; Wilson WD; Wang MZ; Hemphill A
    Parasitology; 2013 Jul; 140(8):929-51. PubMed ID: 23561006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubulin as an antiprotozoal drug target.
    Werbovetz KA
    Mini Rev Med Chem; 2002 Dec; 2(6):519-29. PubMed ID: 12370037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphibian antimicrobial peptides and Protozoa: lessons from parasites.
    Rivas L; Luque-Ortega JR; Andreu D
    Biochim Biophys Acta; 2009 Aug; 1788(8):1570-81. PubMed ID: 19046939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two lysosomal membrane proteins, LGP85 and LGP107, are delivered to late endosomes/lysosomes through different intracellular routes after exiting from the trans-Golgi network.
    Niwa K; Tanaka R; Murase H; Ishikawa T; Fujita H; Himeno M; Tanaka Y
    Biochem Biophys Res Commun; 2003 Feb; 301(4):833-40. PubMed ID: 12589788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
    Darkin-Rattray SJ; Gurnett AM; Myers RW; Dulski PM; Crumley TM; Allocco JJ; Cannova C; Meinke PT; Colletti SL; Bednarek MA; Singh SB; Goetz MA; Dombrowski AW; Polishook JD; Schmatz DM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13143-7. PubMed ID: 8917558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysosomal membrane protein composition, acidic pH and sterol content are regulated via a light-dependent pathway in metazoan cells.
    Swetha MG; Sriram V; Krishnan KS; Oorschot VM; ten Brink C; Klumperman J; Mayor S
    Traffic; 2011 Aug; 12(8):1037-55. PubMed ID: 21535339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.